K. Takeda

A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G).

Nobuyuki Yamamoto, Nobuyuki Katakami, Shinji Atagi et al. · Journal of Clinical Oncology · 2011 · 25 citations

Medicine, Oncology, Pharmacology +16

A Phase I intermittent dose-escalation trial of ZD1839 (IressaTM) in Japanese patients with solid malignant tumors

Takeshi Tamura, Kimihiko Nakagawa, M. Fukuoka et al. · Lung Cancer · 2000 · 17 citations

Pharmacy, Oncology, Pharmacology +5

Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

K. Takeda, Satoshi Kudoh, Ken Nakagawa et al. · Journal of Clinical Oncology · 2005 · 13 citations

Medicine, Oncology, Pharmacology +10